IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG • NL0015000LU4

19.15 EUR
+0.02 (+0.1%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

IVG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on IVG.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year IVG was profitable.
  • IVG had a positive operating cash flow in the past year.
  • Each year in the past 5 years IVG has been profitable.
  • Each year in the past 5 years IVG had a positive operating cash flow.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.48%, IVG is doing worse than 63.30% of the companies in the same industry.
  • IVG has a Return On Equity of 10.01%. This is in the better half of the industry: IVG outperforms 66.06% of its industry peers.
  • IVG's Return On Invested Capital of 4.17% is on the low side compared to the rest of the industry. IVG is outperformed by 60.55% of its industry peers.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 4.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • The Profit Margin of IVG (1.82%) is worse than 63.30% of its industry peers.
  • In the last couple of years the Profit Margin of IVG has grown nicely.
  • The Operating Margin of IVG (4.33%) is worse than 61.47% of its industry peers.
  • IVG's Operating Margin has improved in the last couple of years.
  • IVG's Gross Margin of 16.00% is on the low side compared to the rest of the industry. IVG is outperformed by 91.74% of its industry peers.
  • In the last couple of years the Gross Margin of IVG has grown nicely.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
  • IVG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • IVG has an Altman-Z score of 1.75. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.75, IVG is in line with its industry, outperforming 43.12% of the companies in the same industry.
  • The Debt to FCF ratio of IVG is 9.94, which is on the high side as it means it would take IVG, 9.94 years of fcf income to pay off all of its debts.
  • IVG's Debt to FCF ratio of 9.94 is on the low side compared to the rest of the industry. IVG is outperformed by 64.22% of its industry peers.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that IVG has dependencies on debt financing.
  • IVG has a worse Debt to Equity ratio (1.29) than 83.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.75
ROIC/WACC0.57
WACC7.3%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.91. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a Current ratio of 1.91. This is in the better half of the industry: IVG outperforms 67.89% of its industry peers.
  • IVG has a Quick Ratio of 1.38. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG's Quick ratio of 1.38 is fine compared to the rest of the industry. IVG outperforms 77.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for IVG have decreased strongly by -44.23% in the last year.
  • IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.20% yearly.
  • Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -8.94% in the last year.
  • The Revenue has been growing slightly by 5.22% on average over the past years.
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.30% on average over the next years. This is a very strong growth
  • IVG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.30% yearly.
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.51, the valuation of IVG can be described as correct.
  • IVG's Price/Earnings ratio is a bit cheaper when compared to the industry. IVG is cheaper than 75.23% of the companies in the same industry.
  • IVG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.10.
  • The Price/Forward Earnings ratio is 9.00, which indicates a very decent valuation of IVG.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaper than 91.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, IVG is valued rather cheaply.
Industry RankSector Rank
PE 16.51
Fwd PE 9
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 74.31% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than the industry average as 77.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 6.43
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • IVG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IVG's earnings are expected to grow with 39.30% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y50.33%
EPS Next 3Y39.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • IVG has a Yearly Dividend Yield of 1.73%.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.42.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 33.46% of its income as dividend. This is a sustainable payout ratio.
DP33.46%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVECO GROUP NV

BIT:IVG (2/27/2026, 7:00:00 PM)

19.15

+0.02 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.19B
Revenue(TTM)13.92B
Net Income(TTM)263.00M
Analysts70.77
Price Target20.11 (5.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 9
P/S 0.36
P/FCF 8.83
P/OCF 3.66
P/B 1.98
P/tB 7.98
EV/EBITDA 6.43
EPS(TTM)1.16
EY6.06%
EPS(NY)2.13
Fwd EY11.11%
FCF(TTM)2.17
FCFY11.32%
OCF(TTM)5.23
OCFY27.32%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)0.2
PEG (5Y)N/A
Graham Number15.9
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 4.17%
ROICexc 5.08%
ROICexgc 6.33%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.75
F-Score6
WACC7.3%
ROIC/WACC0.57
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)159.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A
EBIT growth 1Y-33.08%
EBIT growth 3Y3.22%
EBIT growth 5YN/A
EBIT Next Year116.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.42%
FCF growth 3Y7.24%
FCF growth 5Y37.52%
OCF growth 1Y12%
OCF growth 3Y-17.96%
OCF growth 5Y6.81%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 7 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Undervalued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 4 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to grow by 83.33% in the next year.